Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Multiple control channels for multicast replication in a network
Visual voicemail (VVM) recovery
Environmental gesture recognition
Double sided lens film with decorative optical pattern and process for making the same
Lubricating oil composition for refrigerators and compressors with the composition
Gastrointestinal motility control
Method, apparatus and system for transmitting multimedia broadcast multicast service notification message
  Randomly Featured Patents
Method of determining oxygen precipitation behavior in a silicon monocrystal
Powder dispersant for hydraulic compositions
Heart-sound detecting apparatus
Composition for preparing rare earth-iron-boron-permanent magnets
Multi-fluid applicator
Electric stove for kitchen
Bed lifting system
Internal bus termination technique for integrated circuits with local process/voltage/temperature compensation
Impact indication of thread-specific events in a non-stop debugging environment